Beta Drugs Limited Share Price & Analysis
₹2,478.4▲ +1.60%Updated 21 Jul 2026, 05:01 pm IST
LTP
₹2,478.4
+1.6%
Open
₹—
High
₹2,495.4
Low
₹2,383.9
Close
₹2,478.4
52W High
₹2,424
52W Low
₹990
Volume
51K
Lot Size
1
Sector
Healthcare
Market Cap
₹2K Cr
Face Value
₹10
Small Cap
Price Chart
Fundamentals
P/E
54.5
Sector P/E
54.4
P/B
5.86
EPS
₹40.85
ROE
18.8%
ROCE
19.2%
D/E Ratio
0.6
Div Yield
0%
Book Value
₹241
+
Strengths
- ✓Strong return on equity (ROE 18.8%)
- ✓Efficient capital deployment (ROCE 19.2%)
−
Concerns
- ✗Trading near 52-week high (₹2,424)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,944 | ₹4.6L Cr | 37.3 | 5.59 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹7,388 | ₹1.9L Cr | 73.4 | 11.71 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹5,040 | ₹1.6L Cr | 73.6 | 20.32 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,939 | ₹1.3L Cr | 64.9 | 13.56 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,416 | ₹1.1L Cr | 30.1 | 3.32 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,123 | ₹1.1L Cr | 21 | 4.17 | 21.2 | 21.1 | 0.38 |
| LUPIN Lupin Limited | ₹2,405 | ₹1.1L Cr | 19.6 | 4.9 | 28.7 | 29.9 | 0.32 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
BETA · as of Dec 2025
Promoters66.73%
FII1.15%▼0.01
DII0.17%▲0.01
Public31.95%
| Category | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|
| Promoters | 66.73% | 66.73% | 66.73% | 66.73% | 66.73% | 66.73% |
| FII | 0.32% | 0.32% | 0.32% | 0.90% | 1.16% | 1.15% |
| DII | 0.02% | 0.02% | 0.06% | 0.12% | 0.16% | 0.17% |
| Public | 32.93% | 32.92% | 32.87% | 32.25% | 31.95% | 31.95% |
About Beta Drugs Limited
Beta Drugs Ltd is engaged in manufacturing of a wide range of oncology (anti-cancer) drugs in India. It has operations in the domestic and export markets.[1]
Healthcare · Pharmaceuticals & Biotechnology
Related Analysis
Frequently Asked Questions
What is Beta Drugs Limited share price today?▾
Beta Drugs Limited (BETA) is currently trading at ₹2,478.4 on NSE, up 1.60% as of the last market session. Prices update daily after market close on MarketNetra.
Is Beta Drugs Limited available in F&O (Futures & Options)?▾
Yes, Beta Drugs Limited (BETA) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Beta Drugs Limited 52-week high and low?▾
Beta Drugs Limited's 52-week high is ₹2,424 and the 52-week low is ₹990. The current price of ₹2,478.4 is -2.2% below the 52W high.
What is Beta Drugs Limited P/E ratio?▾
Beta Drugs Limited's current P/E ratio is 54.5. This indicates the market is paying ₹54.5 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Beta Drugs Limited options?▾
Beta Drugs Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade BETA options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.